ASAM Drug Testing Pocket Guide

Drug Testing Pocket Guide

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/840070

Contents of this Issue

Navigation

Page 31 of 35

32 Methadone Analyte Not Specified 3–11 days [300] (maintenance dose) 1–3 days [5] (occasional use) 3–5 days [5] (chronic use) Methadone 2–4 days [300; 300] 7 days [100] 24 hours [20] EDDP 7 days [100] Buprenorphine Analyte Not Specified 4 days [0.5] Buprenorphine 7 days [0.5] 5 days [1] Norbuprenorphine 7 days [0.5] Benzodiazepines Short Acting Analyte Not Specified 24 hours [300] 2 days [100] Intermediate Acting Analyte Not Specified 1–12.5 days [300] 5 days [100] Long Acting Analyte Not Specified 30 days [200; 200] Diazepam Analyte Not Specified 2–7 days [500] 5–8 days [300] 10 days [100] 7–21 days [NS] 1–3 days [NS] 5–50 hours [NS] Nordiazepam 6–24 days [300] 10 days [100] Table 7. Windows of Detection Table (cont'd) Drug Target Analyte Detection Time in Urine [cutoff (ng/mL) initial; confirm] Detection Time in Oral Fluid [cutoff (ng/mL) initial; confirm] Detection Time in Blood [cutoff (ng/mL)] Windows of Detection Table

Articles in this issue

Archives of this issue

view archives of ASAM Drug Testing Pocket Guide - Drug Testing Pocket Guide